US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride

Patent 11174240 was granted and assigned to Aptabio Therapeutics on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Aptabio Therapeutics

Current Assignee

Aptabio Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11174240

Date of Patent

November 16, 2021

Patent Application Number

16605380

Date Filed

April 20, 2018

Patent Primary Examiner

‌

Noble E Jarrell

Patent abstract

The present invention relates to a novel crystalline 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride, a method for preparing the compound, and a pharmaceutical composition containing the compound as an active ingredient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API